USU's Dr. Craig Shriver, director of the Murtha Cancer Research Program/Murtha Cancer Center, will lead a Department of Defense Cancer Moonshot Roundtable on May 4. (Courtesy Photo).
Throughout the day on May 4, numerous roundtable conversations will be held by various Cancer Cabinet agencies, highlighting initiatives and progress made across the federal government. The DOD’s roundtable discussion, led by Dr. Shriver, will focus on the military’s efforts to support this initiative. The public is invited to view the roundtable discussion via livestream. Several active duty cancer survivors will share their experiences and discuss the care they have received within the Military Health System.
“Uniformed Services University’s Murtha Cancer Center Research Program is excited to be leading the Department of Defense’s efforts and conversations around the White House initiative for Cancer Moonshot 2,” Shriver said. “We developed two robust and ongoing programs during the original Cancer Moonshot and will leverage those lessons-learned as well as new opportunities to support the nation’s warfighters and veterans through our new DOD initiatives.”
Among the many efforts to support this initiative, the DOD will expand its signature clinical research program known as APOLLO, or Applied Proteogenomics Organizational Learning and Outcomes network. APOLLO launched in 2016 and incorporates proteogenomics into patient care as a way of looking beyond the genome, into the activity and expression of the proteins that a genome encodes. To date, this network includes 15 DOD and Veterans Affairs hospitals. It now includes studies looking at lung, breast, prostate, ovarian, pancreatic, testicular, and brain cancers, and has been expanded to all cancer types. The program will also be expanding its trial network to include every DOD hospital.
To join the virtual roundtable on May 4 from 1 to 2 p.m., visit this link to the virtual Roundtable.